Experimental mouse model of pemphigus vulgaris: Passive transfer of nondesmoglein 1 and 3 antibodies

Animal Models of Human Inflammatory Skin Diseases

Volumn , Issue , 2003, Pages 285-306

  Nguyen, Vu Thuong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 9444230301     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (95)

1. Beutner, E. and Jordon, R., Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining, Proc. Soc. Exp. Biol. Med., 117, 505, 1964.
2. Holubar, K., et al., Studies in immunodermatology. 3. Induction of intraepithelial lesions in monkeys by intramucosal injections of pemphigus antibodies, Int. Arch. Allergy Appl. Immunol., 44, 631, 1973.
3. Michel, B. and Ko, C.S., An organ culture model for the study of pemphigus acantholysis, Br. J. Dermatol., 96, 295, 1977.
4. Schiltz, J.R. and Michel, B., Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum, J. Invest. Dermatol., 67, 254, 1976.
5. Anhalt, G.J., et al., Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease, N. Engl. J. Med., 306, 1189, 1982.
6. Anhalt, G.J., et al., Defining the role of complement in experimental pemphigus vulgaris in mice, J. Immunol., 137, 2835, 1986.
7. Zhu, S., et al., The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study, Br. J. Dermatol., 136, 878, 1997.
8. Boulinguez, S., et al., Ultrastructural localisation of pemphigus vulgaris and pemphigus foliaceus antigens by indirect immunoelectron microscopy. Apropos of 7 cases, Ann. Dermatol. Venereol., 122, 417, 1995.
9. Takigawa, M., et al., Surface distribution of pemphigus antibody-binding substances(s) on isolated guinea pig epidermal cells: An immunoferritin electron microscopic study, J. Invest. Dermatol., 71, 182, 1978.
10. Ablin, J.R.J. and Beutner, E.H., Precipitation of epithelia antigen(s) with pemphigus-like autoantibodies of rabbit and human pemphigus autoantibodies, Experientia, 24, 1055, 1968.
11. Shu, S.Y. and Beutner, E.H., Isolation and characterization of antigens reactive with pemphigus antibodies, J. Invest. Dermatol., 61, 270, 1973.
12. Diaz, L.A., Patel, H., and Calvanico, N.J., Isolation of pemphigus antigen from human saliva, J. Immunol., 124, 760, 1980.
13. Stanley, J.R. et al, Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes, J. Clin. Invest., 70, 281, 1982.
14. Eyre, R.W. and Stanley, J.R., Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen, J. Clin. Invest., 81, 807, 1988.
15. Peterson, L.L. and Wuepper, K.D., Isolation and purification of a pemphigus vulgaris antigen from human epidermis, J. Clin. Invest., 73, 1113, 1984.
16. Acosta, E. and Ivanyi, L., Identification of pemphigus-like antigens expressed by SCaBER cells, Br. J. Dermatol., 112, 157, 1985.
17. Acosta, E. and Ivanyi, L., Oral epithelial cells as the origin of pemphigus antigen in human saliva, Arch. Oral Biol., 30, 23, 1985.
18. Amagai, M., Klaus-Kovtun, V., and Stanley, J.R., Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion, Cell, 67, 869, 1991.
19. Ishii, K., et al., Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins, J. Immunol., 159, 2010, 1997.
20. Amagai, M., et al., Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent, J. Invest. Dermatol., 105, 243, 1995.
21. Ding, X., et al., The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic, J. Invest. Dermatol., 112, 739, 1999.
22. Kowalczyk, A.P., et al., Pemphigus sera recognize conformationally sensitive epitopes in the aminoterminal region of desmoglein-1, J. Invest. Dermatol., 105, 147, 1995.
23. Ding, X., et al., Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles, J. Invest. Dermatol., 109, 592, 1997.
24. Joly, P., et al., Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus, J. Invest. Dermatol., 108, 469, 1997.
25. Nguyen, V.T., Ndoye, A., and Grando, S.A., Novel human alpha 9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity, Am. J. Pathol., 157, 1377, 2000.
26. Nguyen, V.T., Ndoye, A, and Grando, S.A., Pemphigus vulgaris antibody identifies pemphaxin: a novel keratinocyte annexin-like molecule binding acetylcholine, J. Biol. Chem., 275, 29466, 2000.
27. Wilgram, G.F., Caulfield, J.B., and Lever, W.F., An electron microscopic study of acantholysis in pemphigus vulgaris, J. Invest. Dermatol., 36, 373, 1961.
28. Hashimoto, K. and Lever, W.F., The cell surface coat of normal keratinocytes and of acantholytic keratinocytes in pemphigus: An electron microscopic study, Br. J. Dermatol., 83, 282, 1970.
29. Hashimoto, K. and Lever, W.F., The intercellular cement in pemphigus vulgaris, an electron microscopic study, Dermatologica, 135, 27, 1967.
30. Hashimoto, K. and Lever, W.F., An electron microscopic study on pemphigus vulgaris of the mouth and the skin with special reference to the intercellular cement, J. Invest. Dermatol., 48, 540, 1967.
31. Takahashi, Y., et al., Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a timecourse study of clinical, immunologic, ultrastructural, and cytochemical changes, J. Invest. Dermatol., 84, 41, 1985.
32. Lever, W.F., Pemphigus in Medicine, Talbott, J.H., Ed., Williams and Wilkins, Baltimore, 1953, p. 123.
33. Dumas, V., et al., The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid, Br. J. Dermatol., 140, 1127, 1999.
34. Toth, G.G. and Jonkman, MF, Therapy of pemphigus, Clin. Dermatol. 19, 761, 2001.
35. Swanson, D.L. and Dahl, M.V., Methylprednisolone inhibits pemphigus acantholysis in skin cultures, J. Invest. Dermatol., 81, 258, 1983.
36. Jeffes, E.W., Kaplan, R.P., and Ahmed, A.R., Acantholysis produced in vitro with pemphigus serum: hydrocortisone inhibits acantholysis, while dapsone and 6-mercaptopurine do not inhibit acantholysis, J. Clin. Immunol., 4, 359, 1984.
37. Nguyen, V.T., et al., Pemphigus vulgaris IgG and a corticosteroid exhibit reciprocal effects on keratinocyte adhesion molecules, J. Invest. Dermatol., 119, 227, 2002.
38. Decker, R.H., Mechanism of acantholysis: the effect of cantharidin on oxidative phosphorylation, J. Invest. Dermatol., 42, 465, 1964.
39. Decker, R.H., The identification of a phosphoprotein in acantholytic epidermis, J. Invest. Dermatol., 51, 141, 1968.
40. Decker, R.H., Cantharidin-induced acantholysis, Arch. Dermatol., 94, 509, 1966.
41. Decker, R.H. and McMahon, N.J., Phosphoprotein synthesis in epidermis during acantholysis, Proc. Soc. Exp. Biol. Med., 132, 1178, 1969.
42. Decker, R.H., Activation of a protein kinase during acantholysis, J. Invest. Dermatol., 57, 125, 1971.
43. Li, Y.M. and Casida, J.E., Cantharidin-binding protein: identification as protein phosphatase 2A, A. Proc. Natl. Acad. Sci. U. S. A., 89, 11867, 1992.
44. Honkanen, R.E., Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A, FEBS Lett., 330, 283, 1993.
45. Kitajima, Y., Aoyama, Y., and Seishima, M., Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell datachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C, J. Invest. Dermatol. Symp. Proc., 4, 137, 1999.
46. Kitajima, Y., Inoue, S., and Yaoita, H., Effects of pemphigus antibody on the regeneration of cell-cell contact in keratinocyte cultures grown in low to normal Ca++ concentration, J. Invest. Dermatol., 89, 167, 1987.
47. Seishima, M., et al., Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1, 4, 5-triphosphate in DJM-1 cells, a squamous cell carcinoma line, J. Invest. Dermatol., 104, 33, 1995.
48. Seishima, M., et al., Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction, Arch. Dermatol. Res., 291, 606, 1999.
49. Osada, K., Seishima, M., and Kitajima, Y., Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes, J. Invest. Dermatol., 108, 482, 1997.
50. Aoyama, Y., Owada, M.K., and Kitajima, Y., A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes, Eur. J. Immunol., 29, 2233, 1999.
51. Farb, R.M., Dykes, R., and Lazarus, G.S., Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase, Proc. Natl. Acad. Sci. U. S. A., 75, 459, 1978.
52. Baird, J., et al., mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis, J. Invest. Dermatol., 95, 548, 1990.
53. Hashimoto, K., et al., Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells: a mechanism for the loss of epidermal cohesion and blister formation, J. Exp. Med., 157, 259, 1983.
54. Seishima, M., et al., Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes, J. Invest. Dermatol., 109, 650, 1997.
55. Xue, W., Hashimoto, K., and Toi, Y., Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis, J. Cutan. Pathol., 25, 469, 1998.
56. Morioka, S., Naito, K., and Ogawa, H., The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis, J. Invest. Dermatol., 76, 337, 1981.
57. Naito, K., et al., Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mice and skin explants: effects of synthetic and plasma proteinase inhibitors on pemphigus acantholysis, J. Invest. Dermatol., 93, 173, 1989.
58. Woo, T.Y., et al., Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro, J. Invest. Dermatol., 81, 115s, 1983.
59. Hashimoto, K., et al., Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor, J. Invest. Dermatol., 92, 310, 1989.
60. Amagai, M., et al., Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus, Br. J. Dermatol., 140, 351, 1999.
61. Veldman, C., et al., Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HL.A. class II alleles, J. Immunol., 170, 635, 2003.
62. Lin, M.S., et al., Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris, J. Clin. Invest., 99, 31, 1997.
63. Amagai, M., et al., Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic, J. Clin. Invest., 90, 919, 1992.
64. Tsunoda, K., et al., Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3, J. Immunol., 170, 2170, 2003.
65. Allen, E., Yu, Q.C., and Fuchs, E., Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation, J. Cell Biol., 133, 1367, 1996.
66. Whittock, N.V., et al., Striate palmoplantar keratoderma resulting from desmoplakin haploinsufficiency, J. Invest. Dermatol., 113, 940, 1999.
67. Rickman, L., et al., N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma, Hum. Mol. Genet., 8, 971, 1999.
68. Armstrong, D.K., et al., Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma, Hum. Mol. Genet., 8, 143, 1999.
69. Nguyen, V.T., et al., Molecular cloning and partial characterization of novel keratinocyte annexin-like molecule identified by pemphigus vulgaris antibodies, J. Invest. Dermatol., 110, 486, 1998.
70. Koch, P.J., et al., Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris, J. Cell Biol., 137, 1091, 1997.
71. Lenox, J.M., et al., Postnatal lethality of P-Cadherin/Desmoglein 3 double knockout mice: demonstration of a cooperative effect of these cell adhesion molecules in tissue homeostasis of stratified squamous epithelia, J. Invest. Dermatol., 114, 948, 2000.
72. Pulkkinen, L., et al., Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene, J. Invest. Dermatol., 119, 1237, 2002.
73. Nguyen, V.T., et al., A novel pemphigus vulgaris antigen desmoglein 4 has an central role in keratinocyte adhesion and differentation, in preparation.
74. Montagutelli, X., et al., Vesicle formation and follicular root sheath separation in mice homozygous for deleterious alleles at the balding (bal) locus, J. Invest. Dermatol., 109, 324, 1997.
75. Jordon, R.E., Pemphigus, McGraw-Hill, New York, 1979.
76. Fine, J.-D., Immunobullous Diseases, Churchill Livingstone, London; Edinburgh, 1996.
77. Fine, J.-D., Introduction to Vesicobullous Diseases, Harper and Row, Philadelphia, 1987.
78. Odom, R.B., James, W.D., and Berger, T.G., Andrews’ Diseases of the Skin: Clinical Dermatology, W.B. Saunders, Philadelphia, 2000.
79. Grando, S.A., et al., History and clinical significance of mechanical symptoms in blistering dermatoses: a reappraisal, J. Am. Acad. Dermatol., 48, 86, 2003.
80. Lutz, W., Pemphigus chronicus vulgaris, Lehrbuch Haut-Geschlehts-Krankheiten Basel Karger, 34, 198, 1957.
81. Asboe-Hansen, G., Blister-spread induced by finger pressure, a diagnostic sign in pemphigus, J. Invest. Dermatol., 34, 5, 1960.
82. Nikolskiy, P.V., The Materials on the Study of Pemphigus Foliaceus Cazenavi, Ph.D. diss., 1896, St. Vladimir Emperor University, Kiev, Ukraine (in Russian).
83. Nguyen, V.T., et al., Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions, J. Clin. Invest., 106, 1467, 2000.
84. Kljuic, A., et al., Desmoglein 4 in hair follicle differentiation and epidermal adhesion. Evidence from inherited hypotrichosis and acquired pemphigus vulgaris, Cell, 113, 249, 2003.
85. Mahoney, M.G., et al., Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris, J. Clin. Invest., 103, 461, 1999.
86. Fujita, Y., et al., Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex, Nat. Cell Biol., 4, 222, 2002.
87. Ratcliffe, M.J., Rubin, L.L., and Staddon, J.M., Dephosphorylation of the cadherin-associated p100/p120 proteins in response to activation of protein kinase C in epithelial cells, J. Biol. Chem., 272, 31894, 1997.
88. Rosato, R., et al., Involvement of the tyrosine kinase fer in cell adhesion, Mol. Cell Biol., 18, 5762, 1998.
89. Yap, A.S. and Kovacs, E.M., Direct cadherin-activated cell signaling: a view from the plasma membrane, J. Cell Biol., 160, 11, 2003.
90. Gumbiner, B.M., Signal transduction of beta-catenin, Curr. Opin. Cell Biol., 7, 634, 1995.
91. Green, K.J. and Gaudry, C.A., Are desmosomes more than tethers for intermediate filaments? Nat. Rev. Mol. Cell Biol., 1, 208, 2000.
92. Kljuic, A. and Christiano, A.M., A novel mouse desmosomal cadherin family member, desmoglein 1gamma, Exp. Dermatol., 12, 20, 2003.
93. Pulkkinen, L., et al., Novel member of the mouse desmoglein gene family: Dsg1-beta, Exp. Dermatol., 12, 11, 2003.
94. Talbott, J.H., et al., Metabolic studies on patients with pemphigus, J. Invest. Dermatol., 43, 31, 1940.
95. Kalish, R.S., Possible role for non-desmoglein antigen in pemphigus, J. Invest. Dermatol., 117, 995, 2001.